Unclaimed brand
Our technology leverages military intelligence-grade geospatial AI methods to analyze and interpret complex cellular interactions in a patient’s biopsy, translating them into actionable insights that can accelerate the development of life-saving treatments and diagnostics.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#99030F
Scarlett
153, 3, 15
355, 96, 31
0, 98, 90, 40
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#333333
Mine Shaft
51, 51, 51
0, 0, 20
0, 0, 0, 80
Nucleai is a leading brand that is revolutionizing precision medicine through the power of spatial biology and AI-powered image analysis. Their mission is to provide pharmaceutical companies and clinicians with cutting-edge applications that enhance drug development, support treatment decisions, and improve patient lives. Their technology leverages real-world pathology, clinical, and molecular datasets to better understand cancer biology, optimize patient stratification, and improve patient care.
With access to millions of annotated cells across multiple cancer indications, their algorithms detect and characterize tissue and cell architecture. By computing hundreds of complex feature values and combining spatial features with clinical data, they predict pathology-based spatial biomarkers for accurate response prediction. Nucleai offers an exploratory research platform that empowers researchers to discover novel pathology-based biomarkers, as well as AI-powered clinical trial assays and companion diagnostics development in collaboration with biopharma and clinical laboratories.
With their transformative platform, Nucleai unlocks spatial insights from pathology slides, providing physicians and researchers with invaluable tools to advance precision medicine and make a significant impact on patient outcomes
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
11-50 employees
